ClinicalTrials.Veeva

Menu

In Vivo Glycocalyx as Predictor of Complications After Cardiac Surgery (GLYPOCS)

U

University Hospital, Rouen

Status

Unknown

Conditions

Endothelial Dysfunction
Surgery
Cardiovascular Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT04643535
2020/202/OB

Details and patient eligibility

About

Cardiac surgery has been described as altering endothelium structure and function, notably because of the use of cardiac-pulmonary bypass (CPB). Among the endothelial structure, glycocalyx, the thin layer recovering the endothelial surface, may be altered by the inflammatory process and probably the modification of flow during CPB. Endothelial and glycocalyx integrity are essential for vascular function and glycocalyx destruction is associated with organ failure and mortality. On the other hand, a chronic alteration of glycocalyx is observed in many diseases such as diabetes, hypertension or chronic kidney failure, all pathologies frequently observed in patients benefiting grom cardiac surgery.

Thus the preoperative alteration of glycocalyx may be associated with postoperative organ failure.

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all patients benefiting from a cardiac surgery with cardio-pulmonary bypass

Exclusion criteria

  • impossibility to carry out the measurement by glycocheck device
  • refusal to participate

Trial contacts and locations

1

Loading...

Central trial contact

Emmanuel Besnier, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems